Legal Representation
Attorney
Mark Lebow
USPTO Deadlines
Next Renewal Deadline
184 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-01-07)
Due Date
January 07, 2026
Grace Period Ends
July 07, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
27 events| Date | Code | Type | Description |
|---|---|---|---|
| Jan 7, 2025 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Jul 3, 2022 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| May 8, 2020 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Apr 18, 2020 | FIMP | P | FINAL DISPOSITION PROCESSED |
| Apr 18, 2020 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| Apr 7, 2020 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Jan 7, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Oct 22, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Oct 22, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Oct 19, 2019 | GPNX | P | NOTIFICATION PROCESSED BY IB |
| Oct 2, 2019 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Oct 2, 2019 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Oct 2, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sep 18, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 17, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sep 17, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sep 17, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Apr 5, 2019 | RFNT | P | REFUSAL PROCESSED BY IB |
| Mar 18, 2019 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Mar 18, 2019 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Mar 8, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Mar 7, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Mar 6, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 4, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 4, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 15, 2019 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Feb 14, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 005
Nucleic acid medicines for use in the treatment and prevention of genetic disorders; synthetic biomolecules, namely, synthetic nucleoside, synthetic nucleotide and synthetic nucleic acid for clinical or medical use in the treatment and prevention of genetic disorders
Classification
International Classes
005